Related references
Note: Only part of the references are listed.Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis
Dan Siskind et al.
BRITISH JOURNAL OF PSYCHIATRY (2022)
Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
Stephen J. Kaar et al.
NEUROPHARMACOLOGY (2020)
Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
Yuya Mizuno et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Thomas R. E. Barnes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research
Steven G. Potkin et al.
NPJ SCHIZOPHRENIA (2020)
The impact of clozapine initiation and cessation on psychiatric hospital admissions and bed days: a mirror image cohort study
D. Siskind et al.
PSYCHOPHARMACOLOGY (2019)
Prevalence of treatment-resistant psychoses in the community: A naturalistic study
Katherine Beck et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
The correlation between the quality of life and clinical variables among outpatients with schizophrenia
Abd Al-Hadi Hasan
PSYCHIATRY RESEARCH (2019)
The impact of switching to clozapine on psychiatric hospital admissions: a mirror-image study
P. Kirwan et al.
IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE (2019)
Prescriber and institutional barriers and facilitators of clozapine use: A systematic review
Helene Verdoux et al.
SCHIZOPHRENIA RESEARCH (2018)
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs
Felice Iasevoli et al.
FRONTIERS IN PSYCHIATRY (2018)
The impact of clozapine on hospital use: a systematic review and meta-analysis
R. Land et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Clozapine prescribing in the UK: views and experience of consultant psychiatrists
Tongeji E. Tungaraza et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2015)
Practitioner attitudes to clozapine initiation
S. Gee et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
The practical management of refractory schizophrenia - the Maudsley Treatment REview and Assessment Team service approach
K. Beck et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
Clozapine: a review of clinical practice guidelines and prescribing trends
Stephanie Warnez et al.
BMC PSYCHIATRY (2014)
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
James L. Kennedy et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)
Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation
Oliver D. Howes et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
Jari Tiihonen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Psychiatrists' attitude towards and knowledge of clozapine treatment
J. Nielsen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
The cost-effectiveness of clozapine: a controlled, population-based, mirror-image study
KP Hayhurst et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2002)
Share Paper
